• Explore /
  • Poster
  • / Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial.

Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial.

Abstract Poster

Authors

Markus Hecht

Markus Hecht

Department of Radiation Oncology, Universitatsklinikum Erlangen, Friedrich-Alexander-Universitat Erlangen-Nürnberg, Erlangen, Germany

Markus Hecht , Markus Eckstein , Annett Kallies , Gunther Klautke , Thomas Illmer , Jens von der Grün , Simon Laban , Matthias G. Hautmann , Balint Tamaskovics , Thomas Brunner , Axel Hinke , Benjamin Frey , Sabine Semrau , Arndt Hartmann , Panagiotis Balermpas , Wilfried Budach , Udo S Gaipl , Heinrich Iro , Antoniu-Oreste Gostian , Rainer Fietkau

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT03426657

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 6064)

DOI

10.1200/JCO.2022.40.16_suppl.6064

Abstract #

6064

Poster Bd #

56

Abstract Disclosures

Similar Posters

First Author: Markus Hecht

First Author: Matt D. Galsky

First Author: Matt D. Galsky

First Author: Thomas Powles